CNR1 and diabetic kidney disease: Enhanced CB1R signaling promoted the generation of reactive oxygen species (ROS) in podocytes and cell death, while the blockade of peripheral CB1R with JD5037 prevented and reversed specific symptoms of diabetic nephropathy [130].